These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 20201812)

  • 1. Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):23-32. PubMed ID: 20201812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapies for alcoholism: the old and the new.
    Olive MF
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):2-4. PubMed ID: 20232494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    Expert Opin Drug Saf; 2010 Jan; 9(1):177-88. PubMed ID: 20021295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism.
    Krishnan-Sarin S; O'Malley S; Krystal JH
    Alcohol Res Health; 2008; 31(4):400-7. PubMed ID: 23584013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acamprosate produces its anti-relapse effects via calcium.
    Spanagel R; Vengeliene V; Jandeleit B; Fischer WN; Grindstaff K; Zhang X; Gallop MA; Krstew EV; Lawrence AJ; Kiefer F
    Neuropsychopharmacology; 2014 Mar; 39(4):783-91. PubMed ID: 24081303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate.
    Dahchour A; De Witte P
    Prog Neurobiol; 2000 Mar; 60(4):343-62. PubMed ID: 10670704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of recurrent alcoholism with acamprosate. Neurobiological principles and clinical results].
    Soyka M; Zieglgänsberger W
    Internist (Berl); 1999 Mar; 40(3):330-6. PubMed ID: 10205765
    [No Abstract]   [Full Text] [Related]  

  • 8. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of acamprosate: an overview.
    Zornoza T; Cano MJ; Polache A; Granero L
    CNS Drug Rev; 2003; 9(4):359-74. PubMed ID: 14647529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical pharmacology of acamprosate.
    Kalk NJ; Lingford-Hughes AR
    Br J Clin Pharmacol; 2014 Feb; 77(2):315-23. PubMed ID: 23278595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference.
    Zalewska-Kaszubska J; Cwiek W; Dyr W; Czarnecka E
    Neurosci Lett; 2005 Nov; 388(1):45-8. PubMed ID: 16009491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
    Scott LJ; Figgitt DP; Keam SJ; Waugh J
    CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acamprosate for the adjunctive treatment of alcohol dependence.
    Overman GP; Teter CJ; Guthrie SK
    Ann Pharmacother; 2003; 37(7-8):1090-9. PubMed ID: 12841823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of acamprosate as a treatment against alcohol relapse.
    Kufahl PR; Watterson LR; Olive MF
    Expert Opin Drug Discov; 2014 Nov; 9(11):1355-69. PubMed ID: 25258174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials.
    Boening JA; Lesch OM; Spanagel R; Wolffgramm J; Narita M; Sinclair D; Mason BJ; Wiesbeck GA
    Alcohol Clin Exp Res; 2001 May; 25(5 Suppl ISBRA):127S-131S. PubMed ID: 11391061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acamprosate in the treatment of alcohol dependence.
    Mason BJ
    Expert Opin Pharmacother; 2005 Oct; 6(12):2103-15. PubMed ID: 16197362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential neuroprotective effects of acamprosate.
    Koob GF; Mason BJ; De Witte P; Littleton J; Siggins GR
    Alcohol Clin Exp Res; 2002 Apr; 26(4):586-92. PubMed ID: 11981137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acamprosate--a novel treatment for alcoholism].
    Golovko SI; Zefirov SIu; Golovko AI; Shpilenia LS; Nekrasov IuA
    Eksp Klin Farmakol; 2000; 63(3):70-3. PubMed ID: 10934602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acamprosate--new preclinical research aspects].
    Spanagel R; Mann K
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():61-4. PubMed ID: 15490768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.